Occupational Therapist-Led Work Intervention in Facilitating Work Maintenance or Re-entry to the Workforce in Patients With Stage I to III Breast Cancer Undergoing Chemotherapy

The Evaluation of a Work Intervention to Facilitate Work Maintenance or Re-Entry to the Workforce for Breast Cancer Patients

Status

Terminated

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT03723863

Enrollment

Registered

2018-10-30

Start date

2018-10-25

Completion date

2020-09-22

Last updated

2021-07-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast Cancer, Breast Cancer Stage I, Breast Cancer Stage II, Breast Cancer Stage IIA, Breast Cancer Stage IIB, Breast Cancer Stage III, Breast Cancer Stage IIIA, Breast Cancer Stage IIIB, Breast Cancer Stage IIIc

Brief summary

This trial studies how well occupational therapy (occupational therapist-led work intervention) works in facilitating work maintenance or re-entry to the workforce for stages I to III breast cancer patients who will be undergoing curative intent chemotherapy. Occupational therapy may help cancer patients maintain employment or successfully return to work soon after treatment.

Detailed description

Patients receive in-person occupational therapist-led work consultation.

Interventions

BEHAVIORALOccupational Therapy

Receive in-person occupational therapist-led work consultation

Study design

Allocation

Intervention model

SINGLE_GROUP

Primary purpose

SUPPORTIVE_CARE

Masking

NONE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* Stage I-III breast cancer patients who will be undergoing curative intent chemotherapy * Working in a paid capacity (part or full-time) at time of diagnosis with the intent to maintain or return to work following treatment

Exclusion criteria

* Non-English speaking patients. This study requires completing online questionnaires that are written in English and will not be translated * Patients with a psychiatric or neurological condition that impairs capacity to make decisions

Design outcomes

Primary

Measure	Time frame	Description
Change in perceived work ability	Baseline up to 3 years	Will be measured by the Work Abilities Index (WAI).

Secondary

Measure	Time frame	Description
Change in health related quality of life	Baseline up to 3 years	Will be measured by the Functional Assessment of Cancer Therapy General (FACT-G), a validated measure for quality of life in patients with cancer.
Change in financial toxicity	Baseline up to 3 years	Will be measured by the Comprehensive Score for Financial Toxicity (COST-FACIT), a validated measure for financial toxicity for clinically relevant patient-centered outcomes.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026